The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer’s disease

Rosenberg, P. B.; Mielke, M. M.; Han, D.; Leoutsakos, J. S.; Lyketsos, C. G.; Rabins, P. V.; Zandi, P. P.; Breitner, J. C. S.; Norton, M. C.; Welsh-Bohmer, K. A.; Zuckerman, I. H.; Rattinger, G. B.; Green, R. C.; Corcoran, C.; Tschanz, J. T.

doi:10.1002/gps.3769

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer’s disease

Published Date:

Feb 29 2012

Publisher's site:

http://dx.doi.org/10.1002/gps.3769 New Site Icon

Source:

Int J Geriatr Psychiatry. 2011; 27(12):1248-1257

Language:

English

[PDF-401.07 KB]

Details:

Alternative Title:

Int J Geriatr Psychiatry

Personal Author:

Rosenberg, P. B. ; Mielke, M. M. ; Han, D. ; Leoutsakos, J. S. ; Lyketsos, C. G. ; ... More ▼

Description:

Objective

The use of psychotropic medications in Alzheimer’s disease (AD) has been associated with both deleterious and potentially beneficial outcomes. We examined the longitudinal association of psychotropic medication use with cognitive, functional, and neuropsychiatric symptom (NPS) trajectories among community-ascertained incident AD cases from the Cache County Dementia Progression Study.

Methods

A total of 230 participants were followed for a mean of 3.7 years. Persistency index (PI) was calculated for all antidepressants, selective serotonin reuptake inhibitors (SSRIs), antipsychotics (atypical and typical), and benzodiazepines as the proportion of observed time of medication exposure. Mixed-effects models were used to examine the association between PI for each medication class and Mini-Mental State Exam (MMSE), Clinical Dementia Rating Sum of Boxes (CDR-Sum), and Neuropsychiatric Inventory – Total (NPI-Total) trajectories, controlling for appropriate demographic and clinical covariates.

Results

At baseline, psychotropic medication use was associated with greater severity of dementia and poorer medical status. Higher PI for all medication classes was associated with a more rapid decline in MMSE. For antidepressant, SSRI, benzodiazepine, and typical antipsychotic use, a higher PI was associated with a more rapid increase in CDR-Sum. For SSRIs, antipsychotics, and typical antipsychotics, a higher PI was associated with more rapid increase in NPI-Total.

Conclusions

Psychotropic medication use was associated with more rapid cognitive and functional decline in AD, and not with improved NPS. Clinicians may tend to prescribe psychotropic medications to AD patients at risk of poorer outcomes, but one cannot rule out the possibility of poorer outcomes being caused by psychotropic medications.

Subject:

[+]

Pubmed ID:

22374884

Pubmed Central ID:

PMC3448859

Document Type:

Journal Article

Funding:

U01 GM092654/GM/NIGMS NIH HHS/United States ; AG11380/AG/NIA NIH HHS/United States ; R01MH086881/MH/NIMH NIH HHS/United States ; R01AG21136/AG/NIA NIH HHS/United States ; R15 AG037392/AG/NIA NIH HHS/United States ; ... More ▼

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

	nihms371202.nxml	text/xml
	nihms371202f1.gif	image/gif
	nihms371202f1.jpg	image/jpeg

No Related Documents.

You May Also Like:

Effects of General Medical Health on Alzheimer Progression: the Cache County Dementia Progression Study

Personal Author:

Leoutsakos, Jeannie-Marie S.; Han, Dingfen; Mielke, Michelle M.; Forrester, Sarah N.; Tschanz, JoAnn T.; Corcoran, Chris D.; Green, Robert C.; Norton, Maria C.; Welsh-Bohmer, Kathleen A.; Lyketsos, Constantine G.;

Published Date:

Jun 12 2012

Source:

Int Psychogeriatr. 24(10):1561-1570.

Description:

BackgroundSeveral observational studies suggested a link between health status and rate of decline among individuals with Alzheimer’s disease (AD). We sought to quantify the relationship in a population-based study of incident AD, and to compare gl...

File Type:

[PDF - 306.03 KB]
Decreased Basal Ganglia Activation in Subjects with Chronic Fatigue Syndrome: Association with Symptoms of Fatigue

Personal Author:

Miller, Andrew H.; Jones, James F.; Drake, Daniel F.; Tian, Hao; Unger, Elizabeth R.; Pagnoni, Giuseppe;

Published Date:

May 23 2014

Source:

PLoS One. 2014; 9(5).

Description:

Reduced basal ganglia function has been associated with fatigue in neurologic disorders, as well as in patients exposed to chronic immune stimulation. Patients with chronic fatigue syndrome (CFS) have been shown to exhibit symptoms suggestive of decr...

File Type:

[PDF - 1.05 MB]
Cross-lagged panel analysis of depression and behavioral dysfunction in the first year after moderate-to-severe traumatic brain injury

Personal Author:

Juengst, Shannon B.; Myrga, John M.; Fann, Jesse R.; Wagner, Amy K.;

Published Date:

Mar 15 2017

Source:

J Neuropsychiatry Clin Neurosci. 29(3):260-266.

Description:

Timely treatment of depression and behavioral dysfunction after moderate-to-severe traumatic brain injury (TBI) could improve health, function, and quality of life. The authors hypothesized that 6-month depression would be the stronger contributor to...

File Type:

[PDF - 533.88 KB]
Sleep disruption and the sequelae associated with traumatic brain injury

Personal Author:

Lucke-Wold, Brandon P.; Smith, Kelly E.; Nguyen, Linda; Turner, Ryan C.; Logsdon, Aric F.; Jackson, Garrett J.; Huber, Jason D.; Rosen, Charles L.; Miller, Diane B.;

Published Date:

May 06 2015

Source:

Neurosci Biobehav Rev. 55:68-77.

Description:

Sleep disruption, which includes a loss of sleep as well as poor quality fragmented sleep, frequently follows traumatic brain injury (TBI) impacting a large number of patients each year in the United States. Fragmented and/or disrupted sleep can wors...

File Type:

[PDF - 1.35 MB]
Maintenance Treatment of Depression in Old Age: A Randomized, Double-blind, Placebo-Controlled Evaluation of the Efficacy and Safety of Donepezil Combined with Antidepressant Pharmacotherapy

Personal Author:

Reynolds, Charles F.; Butters, Meryl A.; Lopez, Oscar; Pollock, Bruce G.; Dew, Mary Amanda; Mulsant, Benoit H.; Lenze, Eric J.; Holm, Margo; Rogers, Joan C.; Mazumdar, Sati; Houck, Patricia R.; Begley, Amy; Anderson, Stewart; Karp, Jordan F.; Miller, Mark D.; Whyte, Ellen M.; Stack, Jacqueline; Gildengers, Ariel; Szanto, Katalin; Bensasi, Salem; Kaufer, Daniel I.; Kamboh, M. Ilyas; DeKosky, Steven T.;

Published Date:

Jan 2011

Source:

Arch Gen Psychiatry. 68(1):51-60.

Description:

ContextCognitive impairment in late-life depression is a core feature of the illness.Objectiveto test whether donepezil + antidepressant is superior to placebo + antidepressant in (1) improving cognitive performance and instrumental activities of dai...

File Type:

[PDF - 828.42 KB]